1
|
ARDS Definition Task Force. Ranieri VM,
Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E,
Camporota L and Slutsky AS: Acute respiratory distress syndrome:
The Berlin Definition. JAMA. 307:2526–33. 2012.PubMed/NCBI View Article : Google Scholar
|
2
|
Villar J, Pérez-Méndez L, Blanco J, Añón
JM, Blanch L, Belda J, Santos-Bouza A, Fernández RL and Kacmarek
RM: Spanish initiative for epidemiology, stratification and
therapies for ARDS (SIESTA) network. A universal definition of
ARDS: the PaO2/FiO2 ratio under a standard ventilatory setting-a
prospective, multicenter, validation study. Intensive Care Med.
39:583–92. 2013.PubMed/NCBI View Article : Google Scholar
|
3
|
García-Laorden MI, Lorente JA, Flores C,
Slutsky AS and Villar J: Biomarkers for the acute respiratory
distress syndrome: how to make the diagnosis more precise. Ann
Transl Med. 5(283)2017.PubMed/NCBI View Article : Google Scholar
|
4
|
Matthay MA, Zemans RL, Zimmerman GA, Arabi
YM, Beitler JR, Mercat A, Herridge M, Randolph AG and Calfee CS:
Acute respiratory distress syndrome. Nat Rev Dis Primers.
5(18)2019.PubMed/NCBI View Article : Google Scholar
|
5
|
Villar J, Blanco J and Kacmarek RM:
Current incidence and outcome of the acute respiratory distress
syndrome. Curr Opin Crit Care. 22:1–6. 2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Bellani G, Laffey JG, Pham T, Fan E,
Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley
DF, et al: Epidemiology, patterns of care, and mortality for
patients with acute respiratory distress syndrome in intensive care
units in 50 countries. JAMA. 315:788–800. 2016.PubMed/NCBI View Article : Google Scholar
|
7
|
Trillo-Alvarez C, Cartin-Ceba R, Kor DJ,
Kojicic M, Kashyap R, Thakur S, Thakur L, Herasevich V, Malinchoc M
and Gajic O: Acute lung injury prediction score: Derivation and
validation in a population-based sample. Eur Respir J. 37:604–609.
2011.PubMed/NCBI View Article : Google Scholar
|
8
|
Soto GJ, Kor DJ, Park PK, Hou PC, Kaufman
DA, Kim M, Yadav H, Teman N, Hsu MC, Shvilkina T, et al: Lung
injury prediction score in hospitalized patients at risk of acute
respiratory distress syndrome. Crit Care Med. 44:2182–2191.
2016.PubMed/NCBI View Article : Google Scholar
|
9
|
Zheng F, Pan Y, Yang Y, Zeng C, Fang X,
Shu Q and Chen Q: Novel biomarkers for acute respiratory distress
syndrome: genetics, epigenetics and transcriptomics. Biomark Med.
16:217–231. 2022.PubMed/NCBI View Article : Google Scholar
|
10
|
Yadav H, Bartley A, Keating S, Meade LA,
Norris PJ, Carter RE, Gajic O and Kor DJ: Evolution of validated
biomarkers and intraoperative parameters in the development of
postoperative ARDS. Respir Care. 63:1331–1340. 2018.PubMed/NCBI View Article : Google Scholar
|
11
|
Zhu Z, Liang L, Zhang R, Wei Y, Su L,
Tejera P, Guo Y, Wang Z, Lu Q, Baccarelli AA, et al: Whole blood
microRNA markers are associated with acute respiratory distress
syndrome. Intensive Care Med Exp. 5(38)2017.PubMed/NCBI View Article : Google Scholar
|
12
|
Xu Z, Wu GM, Li Q, Ji FY, Shi Z, Guo H,
Yin JB, Zhou J, Gong L, Mei CX and Wang GS: Predictive value of
combined LIPS and ANG-2 level in critically ill patients with ARDS
risk factors. Mediators Inflamm. 2018(1739615)2018.PubMed/NCBI View Article : Google Scholar
|
13
|
van der Zee P, Rietdijk W, Somhorst P,
Endeman H and Gommers D: A systematic review of biomarkers
multivariately associated with acute respiratory distress syndrome
development and mortality. Crit Care. 24(243)2020.PubMed/NCBI View Article : Google Scholar
|
14
|
Gajic O, Dabbagh O, Park PK, Adesanya A,
Chang SY, Hou P, Anderson H III, Hoth JJ, Mikkelsen ME, Gentile NT,
et al: Early identification of patients at risk of acute lung
injury: Evaluation of lung injury prediction score in a multicenter
cohort study. Am J Respir Crit Care Med. 183:462–70.
2011.PubMed/NCBI View Article : Google Scholar
|
15
|
Bone RC, Balk RA, Cerra FB, Dellinger RP,
Fein AM, Knaus WA, Schein RM and Sibbald WJ: Definitions for sepsis
and organ failure and guidelines for the use of innovative
therapies in sepsis. The ACCP/SCCM consensus conference committee.
American college of chest physicians/society of critical care
medicine. Chest. 101:1644–1655. 1992.PubMed/NCBI View Article : Google Scholar
|
16
|
Li G, Malinchoc M, Cartin-Ceba R, Venkata
CV, Kor DJ, Peters SG, Hubmayr RD and Gajic O: Eight-year trend of
acute respiratory distress syndrome: a population-based study in
Olmsted County, Minnesota. Am J Respir Crit Care Med. 183:59–66.
2011.PubMed/NCBI View Article : Google Scholar
|
17
|
Yadav H, Thompson BT and Gajic O: Fifty
years of research in ARDS. Is acute respiratory distress syndrome a
preventable disease? Am J Respir Crit Care Med. 195:725–736.
2017.PubMed/NCBI View Article : Google Scholar
|
18
|
Kaku S, Nguyen CD, Htet NN, Tutera D, Barr
J, Paintal HS and Kuschner WG: Acute respiratory distress syndrome:
Etiology, pathogenesis, and summary on management. J Intensive Care
Med. 35:723–737. 2020.PubMed/NCBI View Article : Google Scholar
|
19
|
Zarbock A, Singbartl K and Ley K: Complete
reversal of acid-induced acute lung injury by blocking of
platelet-neutrophil aggregation. J Clin Invest. 116:3211–3219.
2006.PubMed/NCBI View
Article : Google Scholar
|
20
|
Jacobson JR, Barnard JW, Grigoryev DN, Ma
SF, Tuder RM and Garcia JG: Simvastatin attenuates vascular leak
and inflammation in murine inflammatory lung injury. Am J Physiol
Lung Cell Mol Physiol. 288:L1026–L1032. 2005.PubMed/NCBI View Article : Google Scholar
|
21
|
Kim BK, Kim S, Kim CY, Kim YJ, Lee SH, Cha
JH and Kim JH: Predictive role of lung injury prediction score in
the development of acute respiratory distress syndrome in Korea.
Yonsei Med J. 62:417–423. 2021.PubMed/NCBI View Article : Google Scholar
|
22
|
Thompson BT, Chambers RC and Liu KD: Acute
respiratory distress syndrome. N Engl J Med. 377:562–572.
2017.PubMed/NCBI View Article : Google Scholar
|
23
|
Terpstra ML, Aman J, van Nieuw Amerongen
GP and Groeneveld AB: Plasma biomarkers for acute respiratory
distress syndrome: A systematic review and meta-analysis*. Crit
Care Med. 42:691–700. 2014.PubMed/NCBI View Article : Google Scholar
|
24
|
Xie J, Méndez JD, Méndez-Valenzuela V and
Aguilar-Hernández MM: Cellular signalling of the receptor for
advanced glycation end products (RAGE). Cell Signal. 25:2185–2197.
2013.PubMed/NCBI View Article : Google Scholar
|
25
|
Tóbon-Velasco JC, Cuevas E and
Torres-Ramos MA: Receptor for AGEs (RAGE) as mediator of NF-kB
pathway activation in neuroinflammation and oxidative stress. CNS
Neurol Disord Drug Targets. 13:1615–1626. 2014.PubMed/NCBI View Article : Google Scholar
|
26
|
Nass N, Trau S, Paulsen F, Kaiser D,
Kalinski T and Sel S: The receptor for advanced glycation end
products RAGE is involved in corneal healing. Ann Anat. 211:13–20.
2017.PubMed/NCBI View Article : Google Scholar
|
27
|
Kwon OS, Decker ST, Zhao J, Hoidal JR,
Heuckstadt T, Sanders KA, Richardson RS and Layec G: The receptor
for advanced glycation end products (RAGE) is involved in
mitochondrial function and cigarette smoke-induced oxidative
stress. Free Radic Biol Med. 195:261–269. 2023.PubMed/NCBI View Article : Google Scholar
|
28
|
Walter JM, Wilson J and Ware LB:
Biomarkers in acute respiratory distress syndrome: From
pathobiology to improving patient care. Expert Rev Respir Med.
8:573–86. 2014.PubMed/NCBI View Article : Google Scholar
|
29
|
Calfee CS, Ware LB, Eisner MD, Parsons PE,
Thompson BT, Wickersham N and Matthay MA: NHLBI ARDS Network.
Plasma receptor for advanced glycation end products and clinical
outcomes in acute lung injury. Thorax. 63:1083–1089.
2008.PubMed/NCBI View Article : Google Scholar
|
30
|
Mauri T, Masson S, Pradella A, Bellani G,
Coppadoro A, Bombino M, Valentino S, Patroniti N, Mantovani A,
Pesenti A and Latini R: Elevated plasma and alveolar levels of
soluble receptor for advanced glycation end-products are associated
with severity of lung dysfunction in ARDS patients. Tohoku J Exp
Med. 222:105–112. 2010.PubMed/NCBI View Article : Google Scholar
|
31
|
Nakamura T, Sato E, Fujiwara N, Kawagoe Y,
Maeda S and Yamagishi S: Increased levels of soluble receptor for
advanced glycation end products (sRAGE) and high mobility group box
1 (HMGB1) are associated with death in patients with acute
respiratory distress syndrome. Clin Biochem. 44:601–604.
2011.PubMed/NCBI View Article : Google Scholar
|
32
|
Jabaudon M, Futier E, Roszyk L, Chalus E,
Guerin R, Petit A, Mrozek S, Perbet S, Cayot-Constantin S, Chartier
C, et al: Soluble form of the receptor for advanced glycation end
products is a marker of acute lung injury but not of severe sepsis
in critically ill patients. Crit Care Med. 39:480–488.
2011.PubMed/NCBI View Article : Google Scholar
|
33
|
Fremont RD, Koyama T, Calfee CS, Wu W,
Dossett LA, Bossert FR, Mitchell D, Wickersham N, Bernard GR,
Matthay MA, et al: Acute lung injury in patients with traumatic
injuries: utility of a panel of biomarkers for diagnosis and
pathogenesis. J Trauma. 68:1121–1127. 2010.PubMed/NCBI View Article : Google Scholar
|
34
|
Ware LB, Koyama T, Zhao Z, Janz DR,
Wickersham N, Bernard GR, May AK, Calfee CS and Matthay MA:
Biomarkers of lung epithelial injury and inflammation distinguish
severe sepsis patients with acute respiratory distress syndrome.
Crit Care. 17(R253)2013.PubMed/NCBI View
Article : Google Scholar
|